Buy or sell Merck stock pre IPO via an EquityZen fund
Merck is a healthcare, life science company.
About Merck Stock
Merck, a leading science and technology company, operates across healthcare, life science and performance materials. Around 56,000 employees work to make a positive difference to millions of people’s lives every day by creating more joyful and sustainable ways to live. From advancing gene- editing technologies and discovering unique ways to treat the most challenging diseases to enabling the intelligence of devices – Merck is everywhere. In 2018, Merck generated sales of €14.8 billion in 66 countries. Scientific exploration and responsible entrepreneurship have been key to Merck’s technological and scientific advances. This is how Merck has thrived since its founding in 1668. The founding family remains the majority owner of the publicly listed company. Merck holds the global rights to the “Merck” name and brand. The only exceptions are the United States and Canada, where the business sectors operate as EMD Serono in healthcare, MilliporeSigma in life science, and EMD Performance Materials. Merck was incorporated in India as E. Merck India Private Limited in 1967. In 2017 they completed 50 years in India, starting out as a pharmaceutical company and growing to become a science and technology business spanning all the sectors of Healthcare, Life Science and Performance Materials. In India Merck has offices, manufacturing sites and IT centres across Mumbai and Bengaluru. Sales offices are located in Delhi, Kolkatta and Hyderabad. Over 2000 employees represent Merck in India.